本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

16.41
+0.31001.93%
盘后16.410.00000.00%19:30 EDT
成交量:75.35万
成交额:1,228.64万
市值:21.83亿
市盈率:7.12
高:16.52
开:16.03
低:15.93
收:16.10
52周最高:19.25
52周最低:10.34
股本:1.33亿
流通股本:1.29亿
量比:1.03
换手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):2.30
每股收益(LYR):2.07
净资产收益率:66.12%
总资产收益率:15.49%
市净率:3.55
市盈率(LYR):7.93

数据加载中...

2021/06/10

重要事件披露

8-K - Current report
2021/05/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/06

重要事件披露

8-K - Current report
2021/04/30

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/27

重要事件披露

8-K - Current report
2021/03/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/24

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/25

重要事件披露

8-K - Current report
2020/10/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership